Bartter syndrome with hypocalcemia Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

💰

1Open funds

Regulatory Watchboard

No FDA or trial events recorded yet for Bartter syndrome with hypocalcemia.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Natpara

Takeda Pharmaceuticals U.S.A., Inc.

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Natpara

(parathyroid hormone)Orphan drugstandard

Takeda Pharmaceuticals U.S.A., Inc.

Parathyroid Hormone [EPC]

12.1 Mechanism of Action NATPARA is a parathyroid hormone. Parathyroid hormone raises serum calcium by increasing renal tubular calcium reabsorption, ...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Bartter syndrome with hypocalcemia.
Search all trials →

Search clinical trials for Bartter syndrome with hypocalcemia →

Recent News & Research

No recent news articles indexed yet for Bartter syndrome with hypocalcemia.
Search PubMed for Bartter syndrome with hypocalcemia →

Browse all Bartter syndrome with hypocalcemia news →

Specialist Network

No specialists currently listed for Bartter syndrome with hypocalcemia.

View all Bartter syndrome with hypocalcemia specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰